These studies have also suggested that the each ncRNA type affects AD pathophysiology through different mechanisms, such as amyloid-beta accumulation, tau phosphorylation, cell apoptosis, and neurotoxicity (Table 1). Here, MAPT is linked to Alzheimer disease.